Pampa Energia reports Q1 revenue $414M vs $401M last year
Adjusted EBITDA Performance: Adjusted EBITDA reached $220M in Q1, marking a 17% increase from Q1 2024, driven by spot energy and PEPE 6 in power generation, along with higher gas volumes and tariff increases.
Challenges Faced: The growth was partially offset by higher operating costs, decreased gas sales to industries and Chile, and reduced production in petrochemicals.
Get Free Real-Time Notifications for Any Stock
Analyst Views on PAM
About PAM
About the author
Utility Companies Face Negative EPS Revisions: CIG and Others at the Bottom
- EPS Revision Overview: As earnings season approaches, analysts have shown a negative trend in earnings revisions for utility companies, with Companhia Energética de Minas Gerais (CIG) receiving an FM grade, indicating declining market confidence in its near-term performance.
- Bottom-Ranked Companies: Middlesex Water (MSEX), ReNew Energy Global (RNW), and UGI (UGI) all received F grades, reflecting analysts' pessimistic outlook on their profitability, which could adversely affect their stock performance.
- Other Affected Firms: Chesapeake Utilities (CPK), Enel Chile (ENIC), and Pampa Energía (PAM) also face D grades, suggesting that their earnings expectations have not met market forecasts, potentially leading to diminished investor confidence.
- Market Outlook Analysis: In the context of the 2026 market rotation, investors should monitor the performance of these utility companies to avoid potential risks in future investment decisions.
Major Stocks Including Janus Henderson, Avidity Biosciences, and BridgeBio Pharma Rise on Monday
U.S. Stock Market Performance: U.S. stocks rose on Monday, with the Nasdaq Composite increasing by approximately 1%.
Janus Henderson Group Takeover Proposal: Shares of Janus Henderson Group surged 16.2% to $48.36 after the company received a non-binding takeover proposal from Trian Fund Management at $46 per share.
Significant Gains in Other Stocks: Avidity Biosciences saw a 43% increase after Novartis announced its acquisition, while several Argentine stocks rose significantly following President Milei's party victory in midterm elections.
Notable Stock Movements: Other notable gainers included Dyne Therapeutics (42.4%), Banco BBVA Argentina (41.7%), and BridgeBio Pharma (15.5%) after positive news regarding their respective companies.
